Latest Cytotoxic T cell Stories
Significant new data presented today at the International Liver Congress™ 2014 indicate that liver cancer (Hepatocellular Carcinoma (HCC)) may be treated by adoptive T-cell therapy.
Autologous Cells Modified with Licensed T Cell Receptor (TCR) IP from University of Pennsylvania Studied for Safety, Bioactivity, and Effectiveness to Treat Multiple Myeloma
Helper cells traditionally thought to only assist killer white blood cells may be the frontline warriors when battling hepatitis A infection.
Scientists have discovered that blocking PD-1 (programmed death-1), an immune molecule that inhibits the immune response to viral infections, can have a significant effect on HIV-like illness in nonhuman primates.
Good news! Researchers have discovered a promising new technique that potentially could turn immune system killer T cells into more effective weapons against infections and possibly cancer.
In a study published in Nature Medicine, Loyola researchers report on a promising new technique that potentially could turn immune system killer T cells into more effective weapons against infections and possibly cancer.
After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success.
Killer T cells begin to divide en route to virus-infected tissue, allowing them to hit the ground running when they arrive.
- A bereavement by loss of parents or children; the state of being orbate; orbation.